Abstract
Purpose of Review
This study aims to discuss the global problem of antimicrobial resistance that has been amplified by international travel and explore stewardship considerations for providers when caring for travelers.
Recent Findings
There are a variety of environmental and societal factors that contribute to the ongoing development and spread of antimicrobial resistance. Now more than ever, there are increasing rates of international travelers each year in the context of similarly rising rates of multi-drug-resistant organisms. With global travel, individuals are at risk for infection and colonization with these multi-drug-resistant organisms and therefore can contribute to further spread of antimicrobial resistance.
Summary
Counseling travelers about infection prevention and pre-travel vaccination is one of the best defenses against the spread of antimicrobial resistance. When a traveler presents for medical care after returning from their trip, a detailed history is crucial to determining possible infectious diagnoses as well as guiding appropriate antimicrobial treatments based on potential exposure to drug-resistant organisms.
Similar content being viewed by others
References and Recommended Reading
Papers of particular interest, published recently, have been highlighted as: • Of importance
CDC. Achievements in public health, 1900–1999: control of infectious diseases. Morb Mortal Wkly Rep. 1999;48:621–9.
Davies J, Davies D. Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev. 2010;74:417–33. https://doi.org/10.1128/MMBR.00016-10.
• Frost I, Van Boeckel TP, Pires J, Craig J, Laxminarayan R. Global geographic trends in antimicrobial resistance: the role of international travel. J Travel Med. 2019;26. https://doi.org/10.1093/jtm/taz036. Impact of travel on global antimicrobial resistance.
O’Neill J. Tackling drug-resistant infections globally: final report and recommendations [Internet]. 2016. Available from: https://amr-review.org/Publications.html. Accessed 05 May 2020.
Boucher HW, Talbot GH, Benjamin DK, Bradley J, Guidos RJ, Jones RN, et al. 10 x ’20 progress–development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America. Clin Infect Dis. 2013;56:1685–94. https://doi.org/10.1093/cid/cit152.
Ruppé E, Andremont A, Armand-Lefèvre L. Digestive tract colonization by multidrug-resistant Enterobacteriaceae in travellers: an update. Travel Med Infect Dis. 2018;21:28–35. https://doi.org/10.1016/j.tmaid.2017.11.007.
Schwartz KL, Morris SK. Travel and the spread of drug-resistant bacteria. Curr Infect Dis Rep. 2018;20:29. https://doi.org/10.1007/s11908-018-0634-9.
WHO. Antimicrobial resistance [Internet]. 2020. Available from: https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance.
Tiong JJL, Loo JSE, Mai C-W. Global antimicrobial stewardship: a closer look at the formidable implementation challenges. Front Microbiol. 1860;2016:7. https://doi.org/10.3389/fmicb.2016.01860.
WHO. Challenges to tackling antimicrobial resistance [Internet]. Anderson M, Cecchini M, Mossialos E, editors. 2020. Available from: https://www.euro.who.int/__data/assets/pdf_file/0007/432790/Challenges-to-tackling-antimicrobial-resistance.pdf. Accessed 05 May 2020.
Aminov RI. A brief history of the antibiotic era: lessons learned and challenges for the future. Front Microbiol. 2010;1:134. https://doi.org/10.3389/fmicb.2010.00134.
Memish ZA, Venkatesh S, Shibl AM. Impact of travel on international spread of antimicrobial resistance. Int J Antimicrob Agents. 2003;21:135–42. https://doi.org/10.1016/s0924-8579(02)00363-1.
• CDC. Antibiotic resistance threats in the United States, 2019 [Internet]. Atlanta, Georgia; 2019. Available from: https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-report-508.pdf. CDC report on antibiotic resistance in the US. Accessed 05 May 2020.
Weber N, Patrick M, Hayter A, Martinsen AL, Gelting R. A conceptual evaluation framework for the water and sanitation for health facility improvement tool (WASH FIT). J Water Sanit Hyg Dev. 2019;9:380–91. https://doi.org/10.2166/washdev.2019.090.
ReAct. Addressing the antibiotic resistance threat-the role of water, sanitation and hygiene [Internet]. 2016. Available from: https://www.reactgroup.org/wp-content/uploads/2018/02/ReAct-Factsheet_AntibioticResistance-WASH-and-Children-Feb-2018.pdf.
WHO. Combatting antimicrobial resistance through water, sanitation, hygiene and infection prevention and control in health care [Internet]. 2020. Available from: https://www.who.int/infection-prevention/en/.
Eltayb A, Barakat S, Marrone G, Shaddad S, Stålsby LC. Antibiotic use and resistance in animal farming: a quantitative and qualitative study on knowledge and practices among farmers in Khartoum, Sudan. Zoonoses Public Health. 2012;59:330–8. https://doi.org/10.1111/j.1863-2378.2012.01458.x.
Holmes AH, Moore LSP, Sundsfjord A, Steinbakk M, Regmi S, Karkey A, et al. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet. 2016;387:176–87. https://doi.org/10.1016/S0140-6736(15)00473-0.
Harvey K, Esposito DH, Han P, Kozarsky P, Freedman DO, Plier DA, Sotir MJ. Surveillance for travel-related disease–GeoSentinel Surveillance System, United States, 1997–2011. MMWR Surveill Summ Centers Dis Control Prev (CDC). 2013;62:1–23.
Saleem Z, Hassali MA, Hashmi FK, Godman B, Saleem F. Antimicrobial dispensing practices and determinants of antimicrobial resistance: a qualitative study among community pharmacists in Pakistan. Fam Med Community Heal. 2019;7: e000138. https://doi.org/10.1136/fmch-2019-000138.
Barker AK, Brown K, Ahsan M, Sengupta S, Safdar N. What drives inappropriate antibiotic dispensing? A mixed-methods study of pharmacy employee perspectives in Haryana, India. BMJ Open. 2017;7: e013190. https://doi.org/10.1136/bmjopen-2016-013190.
Larsson M, Kronvall G, Chuc N, Karlsson I, Lager F, Hanh H, et al. Antibiotic medication and bacterial resistance to antibiotics: a survey of children in a Vietnamese community. Trop Med Int Heal. 2000;5:711–21. https://doi.org/10.1046/j.1365-3156.2000.00630.x.
Dromigny JA, Nabeth P, Juergens-Behr A, Perrier-Gros-Claude JD. Risk factors for antibiotic-resistant Escherichia coli isolated from community-acquired urinary tract infections in Dakar, Senegal. J Antimicrob Chemother. 2005;56:236–9. https://doi.org/10.1093/jac/dki158.
Apisarnthanarak A, Mundy LM. Correlation of antibiotic use and antimicrobial resistance in Pratumthani, Thailand, 2000 to 2006. Am J Infect Control. 2008;36:681–2. https://doi.org/10.1016/j.ajic.2007.10.022.
Che Roos N, Bakar M, Haque M. Knowledge, attitude and practice among Malaysian medical students, doctors, other health professionals and common people regarding antibiotic use, prescribing and resistance: a systematic review. Adv Hum Biol. 2019;9:179–83. https://doi.org/10.4103/AIHB.AIHB_42_19.
Muresu N, Sotgiu G, Are BM, Cossu A, Cocuzza C, Martinelli M, et al. Travel-related typhoid fever: narrative review of the scientific literature. Int J Environ Res Public Health. 2020;17:615. https://doi.org/10.3390/ijerph17020615.
Cantón R, González-Alba JM, Galán JC. CTX-M enzymes: origin and diffusion. Front Microbiol. 2012;3:100. https://doi.org/10.3389/fmicb.2012.00110.
Storberg V. ESBL-producing Enterobacteriaceae in Africa – a non-systematic literature review of research published 2008–2012. Infect Ecol Epidemiol. 2014;4:20342. https://doi.org/10.3402/iee.v4.20342.
van den Bunt G, van Pelt W, Hidalgo L, Scharringa J, de Greeff SC, Schürch AC, et al. Prevalence, risk factors and genetic characterisation of extended-spectrum beta-lactamase and carbapenemase-producing Enterobacteriaceae (ESBL-E and CPE): a community-based cross-sectional study, the Netherlands, 2014 to 2016. Euro Surveill. 2019;24:1800594. https://doi.org/10.2807/1560-7917.
Ye Q, Wu Q, Zhang S, Zhang J, Yang G, Wang J, et al. Characterization of extended-spectrum β-lactamase-producing Enterobacteriaceae from retail food in China. Front Microbiol. 2018;9:1709. https://doi.org/10.3389/fmicb.2018.01709.
Teklu DS, Negeri AA, Legese MH, Bedada TL, Woldemariam HK, Tullu KD. Extended-spectrum beta-lactamase production and multi-drug resistance among Enterobacteriaceae isolated in Addis Ababa, Ethiopia. Antimicrob Resist Infect Control. 2019;8:39. https://doi.org/10.1186/s13756-019-0488-4.
Pitout JDD, Nordmann P, Laupland KB, Poirel L. Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community. J Antimicrob Chemother. 2005;56:52–9. https://doi.org/10.1093/jac/dki166.
Laughlin ME, Chatham-Stephens K, Geissler AL. Travel-related infectious diseases, campylobacteriosis. CDC Yellow B 2020 [Internet]. 2019. Available from: https://wwwnc.cdc.gov/travel/yellowbook/2020/travel-related-infectious-diseases/campylobacteriosis. Accessed 05 May 2020.
Kaakoush NO, Castaño-Rodríguez N, Mitchell HM, Man SM. Global epidemiology of Campylobacter infection. Clin Microbiol Rev. 2015;28:687–720. https://doi.org/10.1128/CMR.00006-15.
Ricotta EE, Palmer A, Wymore K, Clogher P, Oosmanally N, Robinson T, et al. Epidemiology and antimicrobial resistance of international travel-associated Campylobacter infections in the United States, 2005–2011. Am J Public Health. 2014;104:e108–14. https://doi.org/10.2105/AJPH.2013.301867.
Appiah G, Hughes M, Chatham-Stephens K. CDC Yellow Book. CDC Yellow B 2020 [Internet]. 2021. Available from: https://wwwnc.cdc.gov/travel/yellowbook/2020/travel-related-infectious-diseases/typhoid-and-paratyphoid-fever. Accessed 05 May 2020.
Crump JA, Sjölund-Karlsson M, Gordon MA, Parry CM. Epidemiology, clinical presentation, laboratory diagnosis, antimicrobial resistance, and antimicrobial management of invasive Salmonella infections. Clin Microbiol Rev. 2015;28:901–37. https://doi.org/10.1128/CMR.00002-15.
Bodie M, Gale-Rowe M, Alexandre S, Auguste U, Tomas K, Martin I. Addressing the rising rates of gonorrhea and drug-resistant gonorrhea: there is no time like the present. Canada Commun Dis Rep. 2019;45:54–62. https://doi.org/10.14745/ccdr.v45i23a02.
Kirkcaldy RD, Weston E, Segurado AC, Hughes G. Epidemiology of gonorrhoea: a global perspective. Sex Health. 2019;16:401–11. https://doi.org/10.1071/SH19061.
Tien V, Punjabi C, Holubar MK. Antimicrobial resistance in sexually transmitted infections. J Travel Med. 2020;27:taz101. https://doi.org/10.1093/jtm/taz101.
St Cyr S, Barbee L, Workowski KA, Bachmann LH, Pham C, Schlanger K, et al. Update to CDC’s treatment guidelines for gonococcal infection, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1911–6. https://doi.org/10.15585/mmwr.mm6950a6.
Tafuri S, Guerra R, Gallone MS, Cappelli MG, Lanotte S, Quarto M, et al. Effectiveness of pre-travel consultation in the prevention of travel-related diseases: a retrospective cohort study. Travel Med Infect Dis. 2014;12:745–9. https://doi.org/10.1016/j.tmaid.2014.10.012.
Hamer D, Connor B. Travel health knowledge, attitudes and practices among United States travelers. J Travel Med. 2004;11:23–6. https://doi.org/10.2310/7060.2004.13577.
Leder K, Tong S, Weld L, Kain KC, Wilder-Smith A, Von Sonnenburg F, et al. Illness in travelers visiting friends and relatives: a review of the GeoSentinel Surveillance Network. Clin Infect Dis. 2006;43:1185–93. https://doi.org/10.1086/507893.
• Hill DR, Ericsson CD, Pearson RD, Keystone JS, Freedman DO, Kozarsky PE, et al. The practice of travel medicine: guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43:1499–539. https://doi.org/10.1086/508782. IDSA guideline on travel medicine.
• Langford B, Schwartz K. Bringing home unwelcome souvenirs: travel and drug-resistant bacteria. Canada Commun Dis Rep. 2018;44:277–82. https://doi.org/10.14745/ccdr.v44i11a02.Reviewonresistantorganismsthathavebeenassociatedwithtravel.
Angelo KM, Kozarsky PE, Ryan ET, Chen LH, Sotir MJ. What proportion of international travellers acquire a travel-related illness? A review of the literature. J Travel Med. 2017;24:1–8. https://doi.org/10.1093/jtm/tax046.
Chen L, Hochberg N. Preparing international travelers. CDC Yellow B 2020 [Internet]. 2019. Available from: https://wwwnc.cdc.gov/travel/yellowbook/2020/preparing-international-travelers/the-pretravel-consultation. Accessed 05 May 2020.
Ward BJ, Plourde P. Travel and sexually transmitted infections. J Travel Med. 2006;13:300–17. https://doi.org/10.1111/j.1708-8305.2006.00061.x.
Alirol E, Wi TE, Bala M, Bazzo ML, Chen X-S, Deal C, et al. Multidrug-resistant gonorrhea: a research and development roadmap to discover new medicines. PLOS Med. 2017;14: e1002366. https://doi.org/10.1371/journal.pmed.1002366.
Lammert SM, Rao SR, Jentes ES, Fairley JK, Erskine S, Walker AT, et al. Refusal of recommended travel-related vaccines among U.S. international travellers in Global TravEpiNet. J Travel Med. 2016;24:1–7. https://doi.org/10.1093/jtm/taw075.
Sanford C, Mcconnell A, Osborn J. The pretravel Consultation [Internet]. 2016. Available from: http://wwwnc.cdc.gov/travel/page/yellowbook-home-2014. Accessed 05 May 2020.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Antimicrobial Stewardship
Rights and permissions
About this article
Cite this article
Mikell, F., Wooten, W.M., Manandhar, S. et al. Global Travel and Antimicrobial Resistance: a Challenge for Stewardship. Curr Treat Options Infect Dis 14, 1–14 (2022). https://doi.org/10.1007/s40506-021-00257-6
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40506-021-00257-6